58
Participants
Start Date
February 17, 2009
Primary Completion Date
April 18, 2011
Study Completion Date
April 18, 2011
Oxymorphone IR
Open-label, 2 part, ascending dose, single and multiple dose q4-6 hrs up to 48 hrs
The Children's Hospital of Pittsburgh, Pittsburgh
Hershey Medical Center, Hershey
Children's Research Institute, Washington D.C.
St. Joseph's Children's Hospital of Tampa, Tampa
Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville
Indiana University School of Medicine, Indianapolis
Arkansas Children's Hospital, Little Rock
University of Texas Southwestern Medical Center at Dallas, Dallas
The Children's Hospital, Aurora
Stanford University School of Medicine, Stanford
University of Washington, Seattle
Lead Sponsor
Endo Pharmaceuticals
INDUSTRY